Aurinia Pharmaceuticals
AUPH
#4783
Rank
S$2.62 B
Marketcap
S$20.43
Share price
-3.24%
Change (1 day)
93.65%
Change (1 year)

Earnings for Aurinia Pharmaceuticals (AUPH)

Earnings in 2026 (TTM): S$0.17 Billion

According to Aurinia Pharmaceuticals 's latest financial reports the company's current earnings are S$0.29 Billion. In 2025 the company made an earning of S$0.15 Billion, an increase over its 2024 earnings that were of S$15.84 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aurinia Pharmaceuticals from 1999 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) S$0.17 B15.88%
2025 S$0.15 B864.64%
2024 S$15.84 M-116.44%
2023 -S$96.35 Million-31.8%
2022 -S$0.15 Billion-39.4%
2021 -S$0.24 Billion61.9%
2020 -S$0.15 Billion-9.73%
2019 -S$0.16 Billion92.65%
2018 -S$82.8 Million36.39%
2017 -S$60.71 Million106.29%
2016 -S$29.43 Million-15.4%
2015 -S$34.79 Million65.84%
2014 -S$20.98 Million129.82%
2013 -S$9.13 Million-26.6%
2012 -S$12.44 Million
2010 -S$7.04 Million-39.22%
2009 -S$11.59 Million-43.78%
2008 -S$20.61 Million-53.19%
2007 -S$44.02 Million42.97%
2006 -S$30.79 Million-23.03%
2005 -S$40.01 Million36.1%
2004 -S$29.4 Million172.57%
2003 -S$10.79 Million484.61%
2002 -S$1.85 Million
2000 -S$8.76 Million453.81%
1999 -S$1.59 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Regeneron Pharmaceuticals
REGN
S$6.65 B 3,636.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Pieris Pharmaceuticals
PIRS
-S$28.54 Million-116.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
-S$7.08 Million-103.97%๐Ÿ‡บ๐Ÿ‡ธ USA